Seneca Biopharma
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch SNCA and buy or sell other stocks, ETFs, and their options commission-free!About SNCA
Palisade Bio, Inc. is a biopharmaceutical company, which engages in the development of oral therapies that help patients with acute and chronic gastrointestinal complications stemming from post-operative digestive enzyme damage. It offers LB1148, an oral formulation of a broad-spectrum serine protease inhibitor designed to neutralize the activity of potent digestive proteases released from the gut during surgery.
CEOJ. D. Finley
CEOJ. D. Finley
Employees8
Employees8
HeadquartersCarlsbad, California
HeadquartersCarlsbad, California
Founded2011
Founded2011
Employees8
Employees8
SNCA Key Statistics
Market cap20.88M
Market cap20.88M
Price-Earnings ratio-0.50
Price-Earnings ratio-0.50
Dividend yield—
Dividend yield—
Average volume6.28M
Average volume6.28M
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$2.59
52 Week high$2.59
52 Week low$0.53
52 Week low$0.53
Stock Snapshot
Seneca Biopharma(SNCA) stock is priced at $2.29, giving the company a market capitalization of 20.88M. It carries a P/E multiple of -0.50.
On 2025-12-24, Seneca Biopharma(SNCA) stock opened at —, reached a high of —, and a low of —.
The Seneca Biopharma(SNCA)'s current trading volume is 0, compared to an average daily volume of 6.28M.
In the last year, Seneca Biopharma(SNCA) shares hit a 52-week high of $2.59 and a 52-week low of $0.53.
In the last year, Seneca Biopharma(SNCA) shares hit a 52-week high of $2.59 and a 52-week low of $0.53.
People also own
Based on the portfolios of people who own SNCA. This list is generated using Robinhood data, and it’s not a recommendation.